Catalent, Inc. to Post FY2023 Earnings of $2.95 Per Share, Jefferies Financial Group Forecasts (NYSE:CTLT)
Catalent, Inc. to Post FY2023 Earnings of $2.95 Per Share, Jefferies Financial Group Forecasts (NYSE:CTLT)
Catalent, Inc. (NYSE:CTLT – Get Rating) – Analysts at Jefferies Financial Group increased their FY2023 earnings per share (EPS) estimates for Catalent in a report issued on Tuesday, January 24th. Jefferies Financial Group analyst D. Windley now expects that the company will post earnings per share of $2.95 for the year, up from their previous forecast of $2.87. The consensus estimate for Catalent's current full-year earnings is $2.93 per share. Jefferies Financial Group also issued estimates for Catalent's Q4 2023 earnings at $1.12 EPS and FY2024 earnings at $3.13 EPS.
Catalent,Inc.(紐約證券交易所代碼:CTLT-GET Rating)-傑富瑞金融集團的分析師在1月24日星期二發佈的一份報告中上調了對Catalent 2023財年每股收益(EPS)的預期。傑富瑞金融集團(Jefferies Financial Group)分析師D·温德利現在預計,該公司今年的每股收益將達到2.95美元,高於此前預測的2.87美元。對Catalent目前全年收益的普遍預期為每股2.93美元。傑富瑞金融集團還發布了對Catalent 2023年第四季度每股收益1.12美元和2024財年每股收益3.13美元的預期。
Catalent (NYSE:CTLT – Get Rating) last posted its earnings results on Tuesday, November 1st. The company reported $0.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.49 by ($0.24). The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.06 billion. Catalent had a return on equity of 12.55% and a net margin of 8.83%.
Catalent(NYSE:CTLT-GET Rating)最近一次公佈收益結果是在11月1日星期二。該公司公佈本季度每股收益(EPS)為0.25美元,低於市場普遍預期的0.49美元(0.24美元)。該業務本季度營收為10.2億美元,而分析師預期為10.6億美元。Catalent的股本回報率為12.55%,淨利潤率為8.83%。
Catalent Price Performance
催化劑的性價比
CTLT stock opened at $52.27 on Thursday. The business has a fifty day moving average of $46.54 and a two-hundred day moving average of $71.75. The company has a quick ratio of 2.08, a current ratio of 2.86 and a debt-to-equity ratio of 0.87. The stock has a market cap of $9.41 billion, a price-to-earnings ratio of 22.34, a price-to-earnings-growth ratio of 3.42 and a beta of 1.24. Catalent has a 52-week low of $40.69 and a 52-week high of $115.33.
週四,CTLT的股票開盤報52.27美元。該業務的50日移動均線切入位在46.54美元,200日移動均線切入位在71.75美元。該公司的速動比率為2.08,流動比率為2.86,債務權益比為0.87。該股市值為94.1億美元,市盈率為22.34倍,市盈率為3.42倍,貝塔係數為1.24。卡特倫特的52周低點為40.69美元,52周高位為115.33美元。
Insiders Place Their Bets
內部人士下注
In other news, insider Manja Boerman sold 780 shares of the business's stock in a transaction dated Monday, December 5th. The stock was sold at an average price of $51.70, for a total value of $40,326.00. Following the completion of the sale, the insider now directly owns 15,860 shares of the company's stock, valued at approximately $819,962. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider Ricky Hopson sold 643 shares of the business's stock in a transaction dated Monday, January 23rd. The stock was sold at an average price of $49.36, for a total value of $31,738.48. Following the transaction, the insider now owns 16,452 shares in the company, valued at approximately $812,070.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Manja Boerman sold 780 shares of the business's stock in a transaction dated Monday, December 5th. The shares were sold at an average price of $51.70, for a total value of $40,326.00. Following the completion of the transaction, the insider now owns 15,860 shares in the company, valued at approximately $819,962. The disclosure for this sale can be found here. Insiders sold 3,874 shares of company stock valued at $233,414 in the last ninety days. Insiders own 0.58% of the company's stock.
在其他新聞方面,內部人士Manja Boerman在12月5日星期一的一筆交易中出售了780股該公司的股票。這隻股票的平均售價為51.70美元,總價值為40,326.00美元。出售完成後,這位內部人士現在直接擁有該公司15,860股股票,價值約819,962美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,可以通過以下方式獲取美國證券交易委員會網站。在相關新聞中,內部人士裏奇·霍普森在1月23日星期一的一筆交易中出售了643股該公司的股票。這隻股票的平均售價為49.36美元,總價值為31738.48美元。交易完成後,這位內部人士現在擁有該公司16,452股股票,價值約812,070.72美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的,該文件可通過此超鏈接。此外,內部人士Manja Boerman在12月5日星期一的交易中出售了780股該公司的股票。這些股票的平均價格為51.70美元,總價值為40,326.00美元。交易完成後,這位內部人士現在擁有該公司15,860股股票,價值約819,962美元。關於這次銷售的披露可以找到這裏。在過去的90天裏,內部人士拋售了3874股公司股票,價值233,414美元。內部人士持有該公司0.58%的股份。
Hedge Funds Weigh In On Catalent
對衝基金對Catalent持股
Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD increased its position in Catalent by 9.9% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 22,303,561 shares of the company's stock worth $2,392,949,000 after purchasing an additional 2,011,520 shares during the period. Vanguard Group Inc. increased its position in Catalent by 0.9% during the 3rd quarter. Vanguard Group Inc. now owns 19,223,242 shares of the company's stock worth $1,390,994,000 after purchasing an additional 178,443 shares during the period. BlackRock Inc. increased its position in Catalent by 5.2% during the 3rd quarter. BlackRock Inc. now owns 16,086,469 shares of the company's stock worth $1,164,016,000 after purchasing an additional 792,923 shares during the period. State Street Corp increased its position in Catalent by 0.9% during the 3rd quarter. State Street Corp now owns 7,126,800 shares of the company's stock worth $515,695,000 after purchasing an additional 67,054 shares during the period. Finally, Veritas Asset Management LLP increased its position in Catalent by 1.0% during the 3rd quarter. Veritas Asset Management LLP now owns 6,957,775 shares of the company's stock worth $503,465,000 after purchasing an additional 65,734 shares during the period. Institutional investors and hedge funds own 99.38% of the company's stock.
幾家機構投資者和對衝基金最近增持或減持了該業務的股份。Price T Rowe Associates Inc.MD在第二季度將其在Catalent的頭寸增加了9.9%。Price T Rowe Associates Inc.MD現在擁有22,303,561股該公司股票,價值2,392,949,000美元,在此期間又購買了2,011,520股。先鋒集團(Vanguard Group Inc.)在第三季度將其在Catalent的頭寸增加了0.9%。先鋒集團目前持有19,223,242股該公司股票,價值1,390,994,000美元,在此期間又購買了178,443股。貝萊德股份有限公司在第三季度將其在卡特倫特的持倉增加了5.2%。貝萊德股份有限公司在此期間增持了792,923股,目前持有該公司16,086,469股股票,價值1,164,016,000美元。道富集團在第三季度將其在Catalent的頭寸增加了0.9%。道富銀行目前持有該公司7,126,800股股票,價值515,695,000美元,在此期間又購買了67,054股。最後,Veritas Asset Management LLP在第三季度將其在Catalent的頭寸增加了1.0%。Veritas Asset Management LLP在此期間額外購買了65,734股,現在擁有6,957,775股該公司股票,價值503,465,000美元。機構投資者和對衝基金持有該公司99.38%的股票。
About Catalent
關於Catalent
(Get Rating)
(獲取評級)
Catalent, Inc, together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations.
Catalent公司及其子公司在全球範圍內開發和製造藥物、基於蛋白質的生物製劑、細胞和基因療法以及消費者保健產品的解決方案。軟凝膠和口腔技術部門提供用於一系列客户產品的軟膠囊的配方、開發和製造服務,如處方藥、非處方藥、膳食補充劑、單位劑量化粧品和動物保健藥物製劑。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on Catalent (CTLT)
- Chevron Delights Shareholders with $75 Billion in Share Buybacks
- The Future Of E-Commerce: Analysis And New Data
- Levi Strauss Is A Good Fit For Income Investors
- 3 Small Caps That Have Big Upside
- Mullen Automotive: The Good News, The Bad And The Ugly Outlook
- 免費獲取StockNews.com關於Catalent的研究報告(CTLT)
- 雪佛龍以750億美元的股票回購取悦股東
- 電子商務的未來:分析和新數據
- 列維·施特勞斯非常適合收益型投資者
- 3只小盤股有很大的上漲空間
- 馬倫汽車:好消息、壞消息和醜陋的前景
Receive News & Ratings for Catalent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Catalent Daily》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Catalent和相關公司的最新新聞和分析師評級的每日簡要摘要。